Royalty Pharma
Acquisition of royalty interests in marketed and late stage biopharmaceutical products.
Acquisition of royalty interests in marketed and late stage biopharmaceutical products.
Next generation PCR technology that quantifies DNA molecules by Droplet Digitalâ„¢ PCR.